Mount Sinai Medical Center welcomes Steven Hochwald, M.D., MBA, FACS, as the inaugural director of the new Irma and Norman Braman Cancer Center, set to be completed in 2025. Dr. Hochwald will also serve as chief of surgical oncology and holds titles at Columbia University in New York, as part of Mount Sinai’s ongoing affiliation with the Ivy League institution.
A leading pancreatic and gastrointestinal surgical oncologist, and an avid researcher, Dr. Hochwald was recruited from Roswell Park Comprehensive Cancer Center in New York, an NCI-designated institution.
Dr. Hochwald brings over 30 years of clinical experience and research-focused expertise to Mount Sinai’s award-winning cancer program, which holds the only Ivy League affiliation of its kind in South Florida, backed by Columbia University.
A graduate of New York University School of Medicine, Dr. Hochwald received postgraduate training in surgical oncology at Memorial Sloan Kettering Cancer Center and completed an oncology research fellowship at the Memorial Sloan Kettering Cancer Center’s Surgical Metabolism Laboratory. He also earned an MBA at the University of Buffalo (SUNY) School of Management and an executive degree in managing health care delivery at Harvard Business School Executive Education.
